Is Adjuvant 5-FU–Based Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma Beneficial? A Meta-analysis of an Unanswered Question
- 18 May 2006
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 10 (5) , 689-697
- https://doi.org/10.1016/j.gassur.2005.11.006
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Postoperative adjuvant therapy for pancreatic cancerSeminars in Surgical Oncology, 2003
- Treatment of Pancreatic Cancer: Challenge of the FactsWorld Journal of Surgery, 2003
- Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II studyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinomaThe American Journal of Surgery, 2003
- A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancerInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Long‐term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25‐Year ExperienceWorld Journal of Surgery, 2003
- Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM StatementOncology Research and Treatment, 2000
- Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinomaThe American Journal of Surgery, 2000
- Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary RegionAnnals of Surgery, 1999
- Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation ± 5 fluorouracilInternational Journal of Radiation Oncology*Biology*Physics, 1993